We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » District Judge Upholds GSK's Zofran Patents
District Judge Upholds GSK's Zofran Patents
August 9, 2005
A federal judge has ruled against Par Pharmaceutical in a patent battle to launch a generic version of GlaxoSmithKline’s (GSK’s) antinausea cancer drug Zofran.